A new approach to antiplatelet therapy: Inhibitor of GPIb/V/IX-vWF interaction

Yasuo Ikeda, Makoto Handa, Mitsuru Murata, Shinya Goto

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)


Evidence has been presented that the interaction between von Willebrand factor (vWF) and its platelet membrane receptor, the GPIb/V/IX complex, plays an important role in the pathogenesis of arterial thrombosis. A monoclonal antibody against the A1 domain of vWF has been shown to inhibit thrombus formation in the animal model of arterial thrombosis. Based upon these findings, a new approach to treating arterial thrombosis has been proposed by intervening in the interaction between vWF and platelet.

Original languageEnglish
Pages (from-to)44-52
Number of pages9
Issue numberSUPPL. 3
Publication statusPublished - 2000
Externally publishedYes


  • Aggregation
  • Platelet adhesion
  • Quartz crystal microbalance
  • Shear stress
  • von Willebrand factor

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'A new approach to antiplatelet therapy: Inhibitor of GPIb/V/IX-vWF interaction'. Together they form a unique fingerprint.

Cite this